Current Ratio in Pharmaceuticals & Healthcare
How to interpret and apply current ratio specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is Current Ratio?
The current ratio measures a company's ability to pay short-term obligations with its short-term assets โ a basic test of financial health.
Current Ratio = Current Assets รท Current Liabilities
How Current Ratio Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical D/E (leverage context)0.2-0.8x
General benchmark: 1.5-3.0 is healthy. Below 1.0 is a red flag. Banks are excluded.
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener โ to filter pharmaceuticals & healthcare stocks by current ratio and other metrics.
Key Takeaways
- Current Ratio in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.